These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9014589)

  • 1. Von Willebrand factor in the outcome of temporal arteritis.
    Cid MC; Monteagudo J; Oristrell J; Vilaseca J; Pallarés L; Cervera R; Font C; Font J; Ingelmo M; Urbano-Márquez A
    Ann Rheum Dis; 1996 Dec; 55(12):927-30. PubMed ID: 9014589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of von Willebrand factor in patients with temporal arteritis].
    González-Gay MA; Alvarez MD; Machín AJ; Alonso MD; García González J; Cereijo MJ; Bal M
    An Med Interna; 1992 Oct; 9(10):483-6. PubMed ID: 1420759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica.
    Persellin ST; Daniels TM; Rings LJ; Kazmier FJ; Bowie EJ; Hunder GG
    Mayo Clin Proc; 1985 Jul; 60(7):457-62. PubMed ID: 3925247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis.
    Federici AB; Fox RI; Espinoza LR; Zimmerman TS
    Arthritis Rheum; 1984 Sep; 27(9):1046-9. PubMed ID: 6332630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand factor in polymyalgia rheumatica and giant cell arteritis.
    Uddhammar AC
    Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S32-3. PubMed ID: 10948757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological and immunohistochemical determination of von Willebrand factor antigen in serum and biopsy specimens from patients with arteritis temporalis and polymyalgia rheumatica.
    Olsson A; Elling P; Elling H
    Clin Exp Rheumatol; 1990; 8(1):55-8. PubMed ID: 2189625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
    Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica.
    Uddhammar A; Rantapåå-Dahlqvist S; Nilsson TK
    Clin Rheumatol; 1992 Jun; 11(2):211-5. PubMed ID: 1617895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of fibronectin in polymyalgia rheumatica giant cell arteritis.
    Puccetti L; Marotta G; Remorini E; Lucchetti A; Zuccotti M; Petrini G; Baicchi U; Ciompi ML
    Rheumatol Int; 1987; 7(6):249-54. PubMed ID: 3125593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
    Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
    Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications.
    Espinoza LR; Jara LJ; Silveira LH; Martínez-Osuna P; Zwolinska JB; Kneer C; Aguilar JL
    Am J Med; 1991 Apr; 90(4):474-8. PubMed ID: 2012088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis.
    Nordborg E; Andersson R; Tengborn L; Edén S; Bengtsson BA
    Ann Rheum Dis; 1991 May; 50(5):316-20. PubMed ID: 2042987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synchronous variations in the incidence of temporal arteritis and polymyalgia rheumatica in Danish counties. Association with epidemics of Mycoplasma pneumonia infection].
    Elling P; Olsson AT; Elling H
    Ugeskr Laeger; 1997 Jun; 159(26):4123-8. PubMed ID: 9229871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
    Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant cell arteritis.
    Nordborg E; Nordborg C; Bengtsson BA
    Curr Opin Rheumatol; 1992 Feb; 4(1):23-30. PubMed ID: 1543659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
    J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyalgia rheumatica: 125 years of progress?
    Rooney PJ; Rooney J; Balint G; Balint P
    Scott Med J; 2014 Nov; 59(4):220-8. PubMed ID: 25201885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymyalgia rheumatica and temporal arteritis. New aspects of diagnosis, treatment, prognosis and risk of cancer].
    Haga HJ; Magnus JH
    Tidsskr Nor Laegeforen; 1994 Sep; 114(23):2716-8. PubMed ID: 7998012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis.
    Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyalgia rheumatica and temporal arthritis.
    Epperly TD; Moore KE; Harrover JD
    Am Fam Physician; 2000 Aug; 62(4):789-96, 801. PubMed ID: 10969858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.